Literature DB >> 26888656

Fetal alcohol spectrum disorders are clearly brain-based.

Jacquelyn Bertrand1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26888656      PMCID: PMC5466354          DOI: 10.1111/dmcn.13086

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


× No keyword cloud information.
  4 in total

Review 1.  Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies.

Authors:  Philip A May; J Phillip Gossage; Wendy O Kalberg; Luther K Robinson; David Buckley; Melanie Manning; H Eugene Hoyme
Journal:  Dev Disabil Res Rev       Date:  2009

2.  Fetal Alcohol Spectrum Disorders.

Authors:  Janet F Williams; Vincent C Smith
Journal:  Pediatrics       Date:  2015-10-19       Impact factor: 7.124

3.  Soft neurological signs and prenatal alcohol exposure: a population-based study in remote Australia.

Authors:  Barbara R Lucas; Jane Latimer; James P Fitzpatrick; Robyn Doney; Rochelle E Watkins; Tracey W Tsang; Tracy Jirikowic; Heather Carmichael Olson; June Oscar; Maureen Carter; Elizabeth J Elliott
Journal:  Dev Med Child Neurol       Date:  2016-03-15       Impact factor: 5.449

4.  The Lililwan Project: study protocol for a population-based active case ascertainment study of the prevalence of fetal alcohol spectrum disorders (FASD) in remote Australian Aboriginal communities.

Authors:  James P Fitzpatrick; Elizabeth J Elliott; Jane Latimer; Maureen Carter; June Oscar; Manuela Ferreira; Heather Carmichael Olson; Barbara Lucas; Robyn Doney; Claire Salter; Elizabeth Peadon; Genevieve Hawkes; Marmingee Hand
Journal:  BMJ Open       Date:  2012-05-03       Impact factor: 2.692

  4 in total
  1 in total

1.  Prenatal ethanol exposure causes anxiety-like phenotype and alters synaptic nitric oxide and endocannabinoid signaling in dorsal raphe nucleus of adult male rats.

Authors:  Saida Oubraim; Ruixiang Wang; Kathryn Hausknecht; Martin Kaczocha; Roh-Yu Shen; Samir Haj-Dahmane
Journal:  Transl Psychiatry       Date:  2022-10-10       Impact factor: 7.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.